DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
86.58
+0.13 (0.15%)
Sep 16, 2026, 9:30 AM EDT - Market open
DexCom Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 32,672 | 25,885 | 30,377 | 47,945 | 43,740 | 52,042 | |
Market Cap Growth | 9.31% | -14.79% | -36.64% | 9.61% | -15.95% | 46.58% |
Enterprise Value | 32,123 | 25,139 | 30,476 | 47,424 | 43,500 | 51,228 |
Last Close Price | 86.45 | 66.37 | 77.77 | 124.09 | 113.24 | 134.24 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 34.08 | 30.95 | 52.72 | 88.54 | 128.19 | 239.94 |
Forward PE | 30.65 | 27.74 | 40.19 | 76.14 | 110.80 | 168.87 |
PS Ratio | 6.57 | 5.55 | 7.53 | 13.24 | 15.03 | 21.26 |
PB Ratio | 12.45 | 9.43 | 14.45 | 23.18 | 20.52 | 25.49 |
P/TBV Ratio | 13.07 | 9.76 | 15.37 | 25.12 | 22.63 | 26.23 |
P/FCF Ratio | 23.22 | 24.03 | 48.16 | 93.66 | 143.55 | 976.40 |
P/OCF Ratio | 18.66 | 17.97 | 30.70 | 64.06 | 65.33 | 117.61 |
PEG Ratio | 1.45 | 1.28 | 1.62 | 2.92 | 4.01 | 12.06 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.45 | 5.39 | 7.56 | 13.09 | 14.95 | 20.92 |
EV/EBITDA Ratio | 22.86 | 21.60 | 37.27 | 60.51 | 79.51 | 139.28 |
EV/EBIT Ratio | 28.16 | 27.57 | 50.79 | 79.34 | 111.20 | 192.73 |
EV/FCF Ratio | 22.83 | 23.34 | 48.32 | 92.64 | 142.76 | 961.12 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.53 | 0.51 | 1.23 | 1.25 | 1.01 | 1.06 |
Debt / EBITDA Ratio | 0.97 | 1.17 | 3.03 | 3.17 | 3.69 | 5.40 |
Debt / FCF Ratio | 1.00 | 1.30 | 4.10 | 5.07 | 7.04 | 40.49 |
Net Debt / Equity Ratio | -0.21 | -0.22 | 0.00 | -0.06 | -0.15 | -0.28 |
Net Debt / EBITDA Ratio | -0.39 | -0.52 | 0.01 | -0.17 | -0.57 | -1.56 |
Net Debt / FCF Ratio | -0.39 | -0.56 | 0.01 | -0.25 | -1.02 | -10.76 |
Asset Turnover | 0.72 | 0.73 | 0.63 | 0.62 | 0.56 | 0.53 |
Inventory Turnover | 2.88 | 3.18 | 2.81 | 2.76 | 2.76 | 2.54 |
Quick Ratio | 1.37 | 1.54 | 1.24 | 2.38 | 1.74 | 4.51 |
Current Ratio | 1.73 | 1.88 | 1.47 | 2.84 | 2.00 | 5.11 |
Return on Equity (ROE) | 38.49% | 34.50% | 27.63% | 25.78% | 16.35% | 11.21% |
Return on Assets (ROA) | 10.33% | 8.89% | 5.88% | 6.41% | 4.74% | 3.60% |
Return on Invested Capital (ROIC) | 44.49% | 32.94% | 24.09% | 24.24% | 20.77% | 18.50% |
Return on Capital Employed (ROCE) | 27.80% | 21.70% | 16.90% | 12.70% | 11.00% | 6.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.06% | 3.23% | 1.90% | 1.13% | 0.78% | 0.42% |
FCF Yield | 4.31% | 4.16% | 2.08% | 1.07% | 0.70% | 0.10% |
Buyback Yield / Dilution | 2.61% | 1.75% | 3.01% | 0.47% | 0.30% | -2.00% |